is retatrutide a glp 3 Reta (GLP-3) research product Retatrutide / GLP-3: multi-receptor research

Its a real step toward a legal prescription pathway, but a recommendation only not a rule, and not FDA approval

CJC 1295 with DAC : 2 mg once per week CJC 1295 without DAC : 100300 mcg per injection, 12 times per day Many stack CJC 1295 with Ipamorelin for better GH release

The presence of an altered microbiome is often referred to as a state of dysbiosis, which is a problematic term 41 because an altered microbiome in one disease context might be linked with health in another population cohort

It activates two of the same three receptors (GLP-1 and GIP), missing only the glucagon pathway

doi: 10.1016/j.isci.2023.106359